Randomized Controlled Trial of Levamisole Hydrochloride as Adjunctive Therapy in Severe Falciparum Malaria With High Parasitemia
暂无分享,去创建一个
Richard J. Maude | Faridul Islam | Kamolrat Silamut | May Ho | Nicholas P. J. Day | Ridwanur Rahman | Nicholas J. White | Joel Tarning | Md Amir Hossain | Arjen M. Dondorp | K. Silamut | R. Maude | Sue J Lee | N. Day | N. White | K. Chotivanich | M. Ho | A. Dondorp | J. Tarning | K. Plewes | M. A. Faiz | M. Hassan | A. Ghose | R. Rahman | J. Schlatter | Kesinee Chotivanich | Alison Eastaugh | Aniruddha Ghose | Josh Hanson | Sue J. Lee | Katherine Plewes | Prakaykaew Charunwatthana | Gofranul Hoque | P. Charunwatthana | N. Day | M. A. Hossain | J. Hanson | M. Abul Faiz | Mahtab U. Hassan | Emran Bin Yunus | Joel Schlatter | Rachel Lacey | Alison Eastaugh | F. Islam | Rachel Lacey | A. Hossain | Gofranul Hoque | R. Maude | N. White | E. Bin Yunus | M. Abul Faiz | E. Yunus | A. Hossain
[1] Severe falciparum malaria. World Health Organization, Communicable Diseases Cluster. , 2000, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[2] C. Newbold,et al. Intercellular adhesion molecule-1 is an endothelial cell adhesion receptor for Plasmodium falciparum , 1989, Nature.
[3] A. Marson,et al. Routine anticonvulsants for treating cerebral malaria. , 2002, The Cochrane database of systematic reviews.
[4] M. Tempero,et al. Pharmacokinetics of levamisole in cancer patients treated with 5-fluorouracil , 2000, Cancer Chemotherapy and Pharmacology.
[5] E N Jonsson,et al. Xpose--an S-PLUS based population pharmacokinetic/pharmacodynamic model building aid for NONMEM. , 1999, Computer methods and programs in biomedicine.
[6] D. Lesieur,et al. Pharmacokinetics of Levamisole in healthy subjects and cancer patients , 1982, European Journal of Drug Metabolism and Pharmacokinetics.
[7] Nicholas J White,et al. Standardizing the measurement of parasite clearance in falciparum malaria: the parasite clearance estimator , 2011, Malaria Journal.
[8] M. Ho,et al. Synergism of multiple adhesion molecules in mediating cytoadherence of Plasmodium falciparum-infected erythrocytes to microvascular endothelial cells under flow. , 2000, Blood.
[9] N. Day,et al. The effects of dopamine and adrenaline infusions on acid-base balance and systemic haemodynamics in severe infection , 1996, The Lancet.
[10] Ian P. Davies,et al. The use of fluorescein in contact lens aftercare. , 2009, Contact lens & anterior eye : the journal of the British Contact Lens Association.
[11] L. Anderson,et al. Cytoadherence by Plasmodium falciparum-infected erythrocytes is correlated with the expression of a family of variable proteins on infected erythrocytes , 1988, The Journal of experimental medicine.
[12] M. Dietrich,et al. Neither heparin nor acetylsalicylic acid influence the clinical course in human Plasmodium falciparum malaria: a prospective randomized study. , 1991, The American journal of tropical medicine and hygiene.
[13] Kamolrat Silamut,et al. Estimation of the Total Parasite Biomass in Acute Falciparum Malaria from Plasma PfHRP2 , 2005, PLoS medicine.
[14] B. Afolabi,et al. Mannitol and other osmotic diuretics as adjuncts for treating cerebral malaria. , 2004, The Cochrane database of systematic reviews.
[15] J. Fontan,et al. Stability of levamisole oral solutions prepared from tablets and powder. , 2005, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.
[16] C. Plas,et al. Ecto‐alkaline phosphatase considered as levamisole‐sensitive phosphohydrolase at physiological pH range during mineralization in cultured fetal calvaria cells , 1996, Journal of cellular biochemistry.
[17] N. White,et al. A controlled trial of artemether or quinine in Vietnamese adults with severe falciparum malaria. , 1996, The New England journal of medicine.
[18] S. Krudsood,et al. Ursodeoxycholic acid and artesunate in the treatment of severe falciparum malaria patients with jaundice , 2010, Journal of gastroenterology and hepatology.
[19] Sue J Lee,et al. Brain Swelling and Mannitol Therapy in Adult Cerebral Malaria: A Randomized Trial , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[20] K. Silamut,et al. Relation of the stage of parasite development in the peripheral blood to prognosis in severe falciparum malaria. , 1993, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[21] N. Blackwell,et al. The FEAST trial of fluid bolus in African children with severe infection , 2012, The Lancet.
[22] Organización Mundial de la Salud. Guidelines for the treatment of malaria , 2010 .
[23] M. Meremikwu,et al. Iron chelating agents for treating malaria. , 2003, The Cochrane database of systematic reviews.
[24] Kamolrat Silamut,et al. Febrile temperatures induce cytoadherence of ring-stage Plasmodium falciparum-infected erythrocytes , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[25] P. Kubes,et al. Characterization of Plasmodium falciparum-infected erythrocyte and P-selectin interaction under flow conditions. , 1998, Blood.
[26] D. Kwiatkowski,et al. The effect of a monoclonal antibody to tumor necrosis factor on survival from childhood cerebral malaria. , 1996, The Journal of infectious diseases.
[27] S. Satpathy,et al. Severe falciparum malaria , 2004, Indian journal of pediatrics.
[28] N. White,et al. Assessment of the pharmacodynamic properties of antimalarial drugs in vivo , 1997, Antimicrobial agents and chemotherapy.
[29] S. Hoffman,et al. High-dose dexamethasone in quinine-treated patients with cerebral malaria: a double-blind, placebo-controlled trial. , 1988, The Journal of infectious diseases.
[30] D. Karnad,et al. Deferiprone (L1) as an adjuvant therapy for Plasmodium falciparum malaria. , 2002, The Indian journal of medical research.
[31] C. Whitty,et al. A quantitative analysis of the microvascular sequestration of malaria parasites in the human brain. , 1999, The American journal of pathology.
[32] D. Kwiatkowski,et al. Lactic acidosis and hypoglycaemia in children with severe malaria: pathophysiological and prognostic significance. , 1994, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[33] T. Vandamme,et al. Quantitation of levamisole in plasma using high performance liquid chromatography , 1995, European Journal of Drug Metabolism and Pharmacokinetics.
[34] P. Kubes,et al. Recombinant PfEMP1 peptide inhibits and reverses cytoadherence of clinical Plasmodium falciparum isolates in vivo. , 2003, Blood.
[35] P. Brickell,et al. src‐related protein tyrosine kinases are physically associated with the surface antigen CD36 in human dermal microvascular endothelial cells , 1994, FEBS letters.
[36] C. Benjamin,et al. Human vascular endothelial cell adhesion receptors for Plasmodium falciparum-infected erythrocytes: roles for endothelial leukocyte adhesion molecule 1 and vascular cell adhesion molecule 1 , 1992, The Journal of experimental medicine.
[37] K. Silamut,et al. Levamisole inhibits sequestration of infected red blood cells in patients with falciparum malaria. , 2007, The Journal of infectious diseases.
[38] P. Kubes,et al. Visualization of Plasmodium falciparum–Endothelium Interactions in Human Microvasculature , 2000, The Journal of experimental medicine.
[39] P. Kubes,et al. Promiscuity of clinical Plasmodium falciparum isolates for multiple adhesion molecules under flow conditions. , 1997, Journal of immunology.
[40] P. Newton,et al. N-acetylcysteine as adjunctive treatment in severe malaria: A randomized, double-blinded placebo-controlled clinical trial* , 2009, Critical Care Medicine.
[41] Thein-Hlaing,et al. Control of ascariasis through age-targeted chemotherapy: impact of 6-monthly chemotherapeutic regimens. , 1990, Bulletin of the World Health Organization.
[42] C. Ockenhouse,et al. Identification of a platelet membrane glycoprotein as a falciparum malaria sequestration receptor. , 1989, Science.
[43] May Ho,et al. Src-family kinase signaling modulates the adhesion of Plasmodium falciparum on human microvascular endothelium under flow. , 2003, Blood.
[44] J. Barnwell,et al. A human 88-kD membrane glycoprotein (CD36) functions in vitro as a receptor for a cytoadherence ligand on Plasmodium falciparum-infected erythrocytes. , 1989, The Journal of clinical investigation.
[45] K. Maitland,et al. Phase II trial on the use of Dextran 70 or starch for supportive therapy in Kenyan children with severe malaria* , 2010, Critical care medicine.
[46] T. Taylor,et al. Intravenous immunoglobulin in the treatment of paediatric cerebral malaria , 1992, Clinical and experimental immunology.
[47] F. T. Ter Kuile,et al. Plasmodium falciparum: in vitro studies of the pharmacodynamic properties of drugs used for the treatment of severe malaria. , 1993, Experimental parasitology.
[48] N. Day,et al. The pathophysiologic and prognostic significance of acidosis in severe adult malaria , 2000, Critical care medicine.
[49] C. Ince,et al. Direct in vivo assessment of microcirculatory dysfunction in severe falciparum malaria. , 2008, The Journal of infectious diseases.